2026-04-18T14:55:33Zhttps://riubu.ubu.es/oai/request

oai:riubu.ubu.es:10259/100382025-01-25T01:05:39Zcom_10259_6688com_10259_5086com_10259_2604col_10259_6689

00925njm 22002777a 4500 dc Castro de Moura, Manuel author Davalos, Veronica author Planas-Serra, Laura author Alvarez-Errico, Damiana author Arribas, Carles author Ruiz, Montserrat author Aguilera-Albesa, Sergio author Troya, Jesús author Valencia Ramos, Juan author Vélez-Santamaria, Valentina author Rodríguez-Palmero, Agustí author Villar-Garcia, Judit author Horcajada, Juan P. author Albu, Sergiu author Casasnovas, Carlos author Rull, Anna author Reverte, Laia author Dietl, Beatriz author Dalmau, David author Arranz, Maria J. author Llucià-Carol, Laia author Planas, Anna M. author Pérez-Tur, Jordi author Fernandez-Cadenas, Israel author Villares, Paula author Tenorio, Jair author Colobran, Roger author Martin-Nalda, Andrea author Soler-Palacin, Pere author Vidal, Francesc author Pujol, Aurora author Esteller, Manel author 2021-04 Patients infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19), exhibit a wide spectrum of disease behaviour. Since DNA methylation has been implicated in the regulation of viral infections and the immune system, we performed an epigenome-wide association study (EWAS) to identify candidate loci regulated by this epigenetic mark that could be involved in the onset of COVID-19 in patients without comorbidities. 2352-3964 http://hdl.handle.net/10259/10038 10.1016/j.ebiom.2021.103339 Coronavirus SARS-CoV-2 COVID-19 Epigenetics DNA methylation Epigenome-wide association study of COVID-19 severity with respiratory failure